N. meningitidis serogroup B
Showing 1 - 25 of >10,000
Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)
Not yet recruiting
- Meningitis, Meningococcal
- rMenB+OMV NZ
-
Anyang-Si, Gyeonggi-do, Korea, Republic of
- +6 more
Oct 27, 2023
Meningococcal B Disease Trial in Worldwide (rLP2086 vaccine, Pediatric HAV vaccine)
Completed
- Meningococcal B Disease
- rLP2086 vaccine
- Pediatric HAV vaccine
-
Canberra, Garran, Australian Capital Territory, Australia
- +24 more
Aug 30, 2021
MENINGOCOCCAL INFECTION Trial in Finland, Poland (Bivalent rLP2086 Vaccine, Licensed pediatric hepatits A vaccine, Normal
Completed
- MENINGOCOCCAL INFECTION
- Bivalent rLP2086 Vaccine
- +2 more
-
Espoo, Finland
- +14 more
Oct 22, 2020
Neisseria Gonorrhoeae Infection Trial in Chapel Hill (Meningococcal Group B Vaccine)
Completed
- Neisseria Gonorrhoeae Infection
- Meningococcal Group B Vaccine
-
Chapel Hill, North CarolinaUniversity of North Carolina Health Care
Jun 24, 2021
Infections, Meningococcal Trial in Worldwide (rMenB+OMV NZ vaccine, Meningococcal Groups A, C, W and Y Conjugate Vaccine
Active, not recruiting
- Infections, Meningococcal
- rMenB+OMV NZ vaccine
- +5 more
-
Chandler, Arizona
- +111 more
Jul 8, 2022
Infections, Meningococcal Trial in Italy, United States (Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ),
Recruiting
- Infections, Meningococcal
- Meningococcal Group B Vaccine (GSK3536829A) (rMenB+OMV NZ)
- +2 more
-
Phoenix, Arizona
- +56 more
Dec 6, 2022
Meningitis, Meningococcal Trial in Germany, United States (MenABCWY vaccine, Placebo)
Recruiting
- Meningitis, Meningococcal
- MenABCWY vaccine
- Placebo
-
Birmingham, Alabama
- +22 more
Aug 5, 2022
Meningitis, Meningococcal Trial in Worldwide (MenABCWY vaccine, Placebo, MenACWY vaccine)
Active, not recruiting
- Meningitis, Meningococcal
- MenABCWY vaccine
- +3 more
-
Houston, Texas
- +3 more
Jun 1, 2022
Meningoccocal Disease, Meningococcal Meningitis Trial in Hungary, Spain (Bexsero® vaccine (1 dose at study month zero), Bexsero®
Completed
- Meningoccocal Disease
- Meningococcal Meningitis
- Bexsero® vaccine (1 dose at study month zero)
- Bexsero® vaccine (2 doses 1 month apart)
-
Debrecen, Bajcsi Ut 32, Hungary
- +16 more
Nov 24, 2021
Infections, Meningococcal Trial in Worldwide (MenABCWY-2Gen low dose vaccine, MenABCWY-2Gen high dose vaccine, MenABCWY-1Gen
Recruiting
- Infections, Meningococcal
- MenABCWY-2Gen low dose vaccine
- +4 more
-
Espoo, Finland
- +36 more
Dec 22, 2022
Assess Oropharyngeal Carriage of N. Meningitidis in South
Completed
- Neisseria Meningitidis
-
Adelaide, South Australia, AustraliaWomen's and Children's Hosptial
Oct 10, 2021
Meningococcal Vaccine Trial in Finland, Poland, Spain (Nimenrix)
Completed
- Meningococcal Vaccine
- Nimenrix
-
Tampere, Pirkanmaa, Finland
- +13 more
Oct 10, 2022
Meningococcal Invasive Infections at Participating Centers
Recruiting
- Invasive Meningococcal Disease
- surveillance
-
Calgary, Alberta, Canada
- +12 more
Apr 4, 2022
Meningococcal Disease, Infections, Meningococcal Trial in Santiago, Bogota, Panama City (MenABCWY+OMV vaccine)
Completed
- Meningococcal Disease
- Infections, Meningococcal
- MenABCWY+OMV vaccine
-
Santiago, Chile
- +6 more
Jun 24, 2020
Splenectomy; Status Trial (Bexsero)
Not yet recruiting
- Splenectomy; Status
- Bexsero
- (no location specified)
Aug 29, 2023
Gonorrhea Male Trial in Chapel Hill (Cefixime, Ceftriaxone, Ciprofloxacin)
Recruiting
- Gonorrhea Male
- Cefixime
- +6 more
-
Chapel Hill, North CarolinaClinical and Translational Research Center (CTRC) at University
May 19, 2022
Meningococcal Infections Trial in Oakland, Worcester (Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals))
Completed
- Meningococcal Infections
- Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals)
-
Oakland, California
- +1 more
Feb 1, 2021
Gonorrhoea Trial in Decatur (Meningococcal Group B Vaccine, Placebo)
Recruiting
- Gonorrhoea
- Meningococcal Group B Vaccine
- Placebo
-
Decatur, GeorgiaEmory Vaccine Center - The Hope Clinic
Feb 2, 2023
Infections, Meningococcal Trial in Puerto Rico, United States (Bexsero (GSK Biologicals' Meningococcal group-B vaccine/
Recruiting
- Infections, Meningococcal
- Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ)
- +7 more
-
Birmingham, Alabama
- +57 more
Jun 26, 2022
Invasive Meningococcal Disease Trial in Poland, United States (Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria
Completed
- Invasive Meningococcal Disease
- Meningococcal (groups A, C, W, Y) oligosaccharide diphtheria CRM-197 conjugate combined with meningococcal (group B) multicomponent recombinant vaccine + OMV.
- +3 more
-
Birmingham, Alabama
- +12 more
Jun 11, 2020
Meningococcal Disease, Infections, Meningococcal Trial in Taipei (Bexsero®, Routine vaccines)
Completed
- Meningococcal Disease
- Infections, Meningococcal
- Bexsero®
- Routine vaccines
-
Taipei, Taiwan
- +1 more
Aug 13, 2020
Meningitis, Meningococcal Trial in Bamako (Non-adjuvanted study formulation NmCV-5, Adjuvanted study formulation NmCV-5,
Completed
- Meningitis, Meningococcal
- Non-adjuvanted study formulation NmCV-5
- +2 more
-
Bamako, MaliCentre pour le Développement des Vaccins du Mali, ex-Institut Ma
Aug 10, 2021
Meningococcal Vaccine Trial in Czechia, Poland, Turkey (Trumenba)
Recruiting
- Meningococcal Vaccine
- Trumenba
-
Brno 2, Czechia
- +9 more
Jun 20, 2022
HIV, Meningitis Trial in Puerto Rico, United States (Quadrivalent meningococcal conjugate vaccine)
Completed
- HIV Infections
- Meningitis
- Quadrivalent meningococcal conjugate vaccine
-
Alhambra, California
- +36 more
Oct 29, 2021
Hiv, Meningococcal Infections, Pneumococcal Infections Trial in Hvidovre (Neisseria meningitidis oligosaccharide conjugate
Recruiting
- Hiv
- +2 more
- Neisseria meningitidis oligosaccharide conjugate vaccine and recombinant protein-based vaccine
- 13 valent pneumococcal conjugate vaccine and 23 valent pneumococcal polysaccharide vaccine
-
Hvidovre, DenmarkHvidovre Hospital
May 5, 2021